Pinnacle Wealth Planning Services, Inc. Biocryst Pharmaceuticals Inc Transaction History
Pinnacle Wealth Planning Services, Inc.
- $748 Million
- Q2 2025
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 16,962 shares of BCRX stock, worth $121,278. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,962
Previous 12,914
31.35%
Holding current value
$121,278
Previous $96,000
57.29%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
316Shares Held
202MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$147 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$143 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$60.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$60.5 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$40.9 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.33B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...